Feberwee Anneke, Ferguson-Noel Naola, Catania Salvatore, Bottinelli Marco, Wawagema Nadeeka, Gyuranecz Miklos, Gautier-Bouchardon Anne V, Lysnyansky Inna, Wiegel Jeanine, Möller Palau-Ribes Franca, Ramirez Ana S
Royal GD, Deventer, the Netherlands.
Poultry Diagnostic and Research Center, The University of Georgia, Athens, GA, USA.
Avian Pathol. 2025 Apr;54(2):168-174. doi: 10.1080/03079457.2024.2419037. Epub 2024 Nov 25.
(Mg) and (Ms) are regarded as the most important avian mycoplasma species for today's chicken and turkey farming industry from clinical and economical perspectives. Control strategies for Mg and Ms have become more efficient due to investments in mycoplasma research over the last 70 years. These investments have contributed to the further implementation of serological and molecular testing, the development of vaccines, and the improvement of antimicrobial treatment strategies. However, the increasing spotlight on welfare, the pressure on prudent use of antimicrobials, and the expected global increase in poultry production, are going to have an impact on the future control of avian mycoplasmas in commercial poultry. In this paper a group of avian mycoplasma experts discuss the future challenges in mycoplasma control considering the background of these expected changes and the relevance for future avian mycoplasma research.
从临床和经济角度来看，鸡毒支原体（Mg）和滑液支原体（Ms）被视为当今鸡和火鸡养殖业中最重要的禽支原体种类。由于过去70年对支原体研究的投入，Mg和Ms的控制策略变得更加有效。这些投入推动了血清学和分子检测的进一步实施、疫苗的研发以及抗菌治疗策略的改进。然而，对动物福利的日益关注、谨慎使用抗菌药物的压力以及全球家禽产量预期的增长，都将对商业家禽中禽支原体的未来控制产生影响。在本文中，一组禽支原体专家在考虑这些预期变化的背景以及对未来禽支原体研究的相关性的情况下，讨论了支原体控制方面的未来挑战。
